pre-IPO PHARMA

COMPANY OVERVIEW

Espero Pharmaceuticals is a commercial-stage cardiovascular pharmaceutical company engaged in maximizing the commercial value of proven treatments that improve the quality of life for patients.


LOCATION

  • Jacksonville Beach, FL, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease

  • WEBSITE

    https://esperopharma.com/


    CAREER WEBSITE

    https://esperopharma.com/careers/


    SOCIAL MEDIA


    INVESTORS

    amkey-ventures ashhill-biomedical atheneos-capital capital-ten-ii cdib-healthcare hercules-bioventure-partners id-softcapital-group


    PRESS RELEASES


    Jun 25, 2020

    Espero BioPharma Assets Offered For Sale


    Mar 11, 2019

    Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients with End Stage Renal Disease and Atrial Fibrillation


    Mar 11, 2019

    Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients with End Stage Renal Disease and Atrial Fibrillation


    Jan 24, 2019

    Espero BioPharma Provides Update on the Development of Tecarfarin for the Treatment of Mechanical Heart Valve Patients in China


    Oct 9, 2018

    Espero BioPharma Appoints Lee Golden, M.D., as Chief Medical Officer


    For More Press Releases


    Google Analytics Alternative